[Conservative therapy of mastopathy]

Area of Science:

• Oncology
• Pathology
• Endocrinology

Background:

• The term "mastopathy" is imprecise and should be replaced by a histopathological classification for clarity in breast disease diagnosis.
• Understanding the etiology of breast conditions is crucial for developing effective therapeutic strategies.
• Current treatment modalities include hormonal and non-hormonal approaches, highlighting the need for refined therapeutic procedures.

Purpose of the Study:

• To review conservative therapeutic approaches for breast conditions.
• To emphasize the importance of histopathological classification over the general term "mastopathy."
• To present preliminary findings from a randomized study on conservative breast disease treatment.

Main Methods:

• Literature review of conservative therapies for breast conditions.
• Discussion of hormonal and non-hormonal treatment options.
• Presentation of preliminary data from a randomized controlled trial.

Main Results:

• The study highlights the inadequacy of the term "mastopathy" and advocates for precise histopathological classification.
• Current conservative treatments, both hormonal and non-hormonal, are discussed in the context of their efficacy.
• Preliminary results from a randomized study suggest potential shifts in conservative therapeutic procedures for breast conditions.

Conclusions:

• Accurate histopathological classification is essential for defining and treating breast conditions, replacing the ambiguous term "mastopathy."
• The ongoing randomized study's findings may significantly influence future conservative treatment protocols for breast diseases.
• Further research is warranted to optimize conservative management strategies based on precise diagnoses.